According to 36Kr.com, Rishena has completed its Series A financing of tens of million yuan, which is jointly invested by Apon Medical and Rays Venture Capital. Proceeds from the financing will mainly be used for clinical trials, product development, and marketing of the implantable spinal cord stimulator.
Rishena originated from the research project of the new implantable gastric electric stimulator launched by the institute of microelectronics of Tsinghua University and China-Japan Friendship Hospital in 2009. The team has started to develop an implantable neural stimulator. After more than 3 years of practice, the team developed a commercialized prototype of the gastric electric stimulator and vagus nerve stimulator.
In 2013, Rishena was registered in Changzhou, Jiangsu, and completed the development of an implantable gastric electric stimulator and implantable vagus nerve stimulator. In 2015, it carried out clinical trials of the implantable vagus nerve stimulator. At present, this product has passed the clinical test, waiting for the approval of the Food and Drug Administration, and is expected to be on sale this year.
Vagus Nerve Stimulation (VNS) is mainly aimed at the treatment of intractable epilepsy which cannot be solved by drug therapy or excision. The effective rate of VNS for patients with intractable epilepsy is more than 50% (at least reduce the number of attacks by 50%), among which nearly 10% of patients are not attacked at all.
The VNS products of Rishena have a few innovations on the basis of the existing products on the market, including adjusting craft, more comfortable treatment, and better performance. The products can also be controlled remotely so that the patient can avoid remote visits and accept the treatment at home.
About Apon Medical
Founded in 2001, Jiangsu Apon Medical Technology Co., LTD. (Apon Medical) has been actively engaged in making medical health services more comfort in China. The company is striving to become a public device and system integration manufacturer based on mobile Internet technology in the field of pain management and nasal care.